230 related articles for article (PubMed ID: 6331652)
1. Nucleolar accumulation of cyclic adenosine 3':5'-monophosphate receptor proteins during regression of MCF-7 human breast tumor.
Kapoor CL; Grantham F; Cho-Chung YS
Cancer Res; 1984 Aug; 44(8):3554-60. PubMed ID: 6331652
[TBL] [Abstract][Full Text] [Related]
2. Changes in cyclic adenosine 3':5'-monophosphate-dependent protein kinases during the progression of urethan-induced mouse lung tumors.
Butley MS; Stoner GD; Beer DG; Beer DS; Mason RJ; Malkinson AM
Cancer Res; 1985 Aug; 45(8):3677-85. PubMed ID: 2990675
[TBL] [Abstract][Full Text] [Related]
3. Appearance of 50,000- and 52,000-dalton cAMP receptor proteins in the nucleoli of regressing MCF-7 human breast cancer upon estrogen withdrawal.
Kapoor CL; Grantham F; Cho-Chung YS
Cell Biol Int Rep; 1983 Nov; 7(11):937-46. PubMed ID: 6360384
[TBL] [Abstract][Full Text] [Related]
4. Cyclic adenosine 3':5-monophosphate receptor proteins in hormone-dependent and -independent rat mammary tumors.
Cho-Chung YS; Clair T; Schwimmer M; Steinberg L; Rego J; Grantham F
Cancer Res; 1981 May; 41(5):1840-6. PubMed ID: 7214351
[TBL] [Abstract][Full Text] [Related]
5. Cyclic adenosine 3':5'-monophosphate receptor proteins in dysplastic and neoplastic human breast tissue cytosol and their inverse relationship with estrogen receptors.
Handschin JC; Handloser K; Takahashi A; Eppenberger U
Cancer Res; 1983 Jun; 43(6):2947-54. PubMed ID: 6303571
[TBL] [Abstract][Full Text] [Related]
6. Cyclic AMP-dependent protein kinase (cAK) in human B cells: co-localization of type I cAK (RI alpha 2 C2) with the antigen receptor during anti-immunoglobulin-induced B cell activation.
Levy FO; Rasmussen AM; Taskén K; Skålhegg BS; Huitfeldt HS; Funderud S; Smeland EB; Hansson V
Eur J Immunol; 1996 Jun; 26(6):1290-6. PubMed ID: 8647207
[TBL] [Abstract][Full Text] [Related]
7. Cyclic AMP receptor protein and cyclic AMP-dependent protein kinase activity in rabbit peritoneal neutrophils.
Huang CK; Mackin WM; Bormann BJ; Becker EL
J Reticuloendothel Soc; 1983 Nov; 34(5):413-21. PubMed ID: 6644693
[TBL] [Abstract][Full Text] [Related]
8. Functional changes in the regulatory subunit of the type II cyclic adenosine 3':5'-monophosphate-dependent protein kinase isozyme during normal and neoplastic lung development.
Butley MS; Beer DG; Malkinson AM
Cancer Res; 1984 Jun; 44(6):2689-97. PubMed ID: 6327022
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin-E2-induced activation of adenosine 3'-5' cyclic monophosphate-dependent protein kinases of a murine macrophage-like cell line (P388D1).
Yamamoto H; Suzuki T
J Immunol; 1987 Nov; 139(10):3416-21. PubMed ID: 2824605
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of oocyte maturation and cumulus expansion in the mouse oocyte-cumulus cell complex by site-selective analogs of cyclic adenosine monophosphate.
Downs SM; Hunzicker-Dunn M
Dev Biol; 1995 Nov; 172(1):72-85. PubMed ID: 7589815
[TBL] [Abstract][Full Text] [Related]
11. Distribution and properties of type I and type II binding proteins in the cyclic adenosine 3':5'-monophosphate-dependent protein kinase system in Wilms' tumor.
Nakajima F; Imashuku S; Wilimas J; Champion JE; Green AA
Cancer Res; 1984 Nov; 44(11):5182-7. PubMed ID: 6091871
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cyclic adenosine 3':5'-monophosphate-binding protein in N-18 mouse neuroblastoma cells.
Liu AY; Fiske WW; Chen KY
Cancer Res; 1980 Nov; 40(11):4100-8. PubMed ID: 6258772
[TBL] [Abstract][Full Text] [Related]
13. Inverse relation between estrogen receptors and cyclic adenosine 3':5'-monophosphate-binding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
Bodwin JS; Clair T; Cho-Chung YS
Cancer Res; 1978 Oct; 38(10):3410-3. PubMed ID: 210938
[TBL] [Abstract][Full Text] [Related]
14. Increase in type I cyclic adenosine 3':5'-monophosphate-dependent protein kinase activity and specific accumulation of type I regulatory subunits in adenovirus type 12-transformed cells.
Ledinko N; Chan IJ
Cancer Res; 1984 Jun; 44(6):2622-7. PubMed ID: 6327020
[TBL] [Abstract][Full Text] [Related]
15. Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cyclic AMP analogues.
Tagliaferri P; Katsaros D; Clair T; Ally S; Tortora G; Neckers L; Rubalcava B; Parandoosh Z; Chang YA; Revankar GR
Cancer Res; 1988 Mar; 48(6):1642-50. PubMed ID: 2830966
[TBL] [Abstract][Full Text] [Related]
16. A study of cAMP binding proteins on intact and disrupted sperm cells using 8-azidoadenosine 3',5'-cyclic monophosphate.
Schoff PK; Forrester IT; Haley BE; Atherton RW
J Cell Biochem; 1982; 19(1):1-15. PubMed ID: 6288746
[TBL] [Abstract][Full Text] [Related]
17. Comparison of soluble protein kinases from normal rat prostates and prostatic Dunning tumors.
Chung LW; Breitweiser K
Cancer Res; 1983 Jul; 43(7):3297-304. PubMed ID: 6303579
[TBL] [Abstract][Full Text] [Related]
18. Mitotic apparatus and nucleoli compartmentalization of 50,000-dalton type II regulatory subunit of cAMP-dependent protein kinase in estrogen receptor negative MDA-MB-231 human breast cancer cells.
Kapoor CL; Cho-Chung YS
Cell Biol Int Rep; 1983 Jan; 7(1):49-60. PubMed ID: 6299590
[TBL] [Abstract][Full Text] [Related]
19. Retinoylation of the type II cAMP-binding regulatory subunit of cAMP-dependent protein kinase is increased in psoriatic human fibroblasts.
Tournier S; Raynaud F; Gerbaud P; Lohmann SM; Anderson WB; Evain-Brion D
J Cell Physiol; 1996 May; 167(2):196-203. PubMed ID: 8613459
[TBL] [Abstract][Full Text] [Related]
20. Correlation of estrogen receptors and charge alterations of regulatory subunits of cAMP-dependent protein kinases in human mammary tumor cells.
Küng W; Fabbro D; Handloser K; Eppenberger U
Anticancer Res; 1984; 4(3):145-50. PubMed ID: 6465852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
